Back to company

Cyclomedica Danmark ApS: Financial statements 2024

CVR: 16582891

Cyclomedica Danmark ApS (CVR 16582891) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 765,707 and a net result of DKK -5,806 compared with DKK -188,267 the year before. That is a decrease of 7.8% compared with the year before. Equity amounted to DKK 342,903. The solvency ratio was 30%. The company had 2 employees in the financial year.

Gross Profit
765,707 kr.
Profit/Loss
-5,806 kr.
Equity
342,903 kr.
Total Assets
1,142,156 kr.
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-766 t.-6 t.343 t.2
2023-831 t.-188 t.349 t.2
2022-622 t.-394 t.1 mio.3
2021-671 t.-379 t.1.4 mio.3
2020-1.3 mio.115 t.1.9 mio.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Events in 2024

Cyclomedica Danmark ApS: The 2023 annual report is outMay 27, 2024

Cyclomedica Danmark ApS has published its annual report for 2023. Gross profit came to DKK 830,611, and the net result was DKK -188,267.

About Cyclomedica Danmark ApS

Cyclomedica Danmark ApS is a Danish company of the type Anpartsselskab based in Kastrup, founded in 1992. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jan Fritz Rode Jakobsen. The company is owned by Cyclomedia Europe Limited. The company has 3 employees. In 2025, the company reported a gross profit of DKK 559,660 and a net result of DKK 135,961 compared with DKK -5,806 the year before. Equity amounted to DKK 478,864.